Depression is a serious public health problem related to high social costs and risk of suicide, also the leading cause of disability affecting 350 million people worldwide according to the World Health Organization (WHO).
Non-adherence with antidepressant medication is a frequent problem for managing depression.
While depression itself can be associated with negative health outcomes, 1, 2 this study provides support that the impact can be further exacerbated by non-adherence to medication.
In this real-world study of Brazilian patients with depression, non-adherence demonstrated a negative impact on patients' outcomes, specifically to medication satisfaction, quality of life, and work productivity, indicating that medication adherence is an important factor in treatment success.
Further research needs to be conducted to help determine factors leading to non-adherence and identify interventions so adherence can be improved and negative impact lessened. 
CONCLUSION
Non-adherence was significantly associated with lower educational level, working full time, lower income, and public insurance coverage.
Additionally, non-adherence was associated with lower mental health-related quality of life and lower health utilities.
Lastly, non-adherence was associated with greater presenteeism, which can indicate higher indirect costs. 
DISCUSSION
Presenteeism measured by the WPAI was higher for the non-adherent group (42 vs. 37, see Figure 3) . No other significant differences for WPAI items were found.
• All results held significant after controlling for covariates (socio-demographic and health characteristics) using GLM models, apart from differences in hospitalization.
• 
RESULTS
The projection of 1,457 respondents to the 2012 Brazilian population resulted in 14.82 M people taking prescription anti-depressants (7.5% of the total population), of which 75% were classified as adherent and 25% as non-adherent. These proportions are well represented in the sample (79% vs. 21%).
Most respondents were female (70%), and the mean age was 41 years for the adherent group and 38 years for non-adherent ones. Adherents were more educated, had higher household income, insurance and less of them were employed (see Table 1 ).
Non-adherent respondents reported significantly more severe depression (22% vs. 17% with PHQ-9 score ≥ 15) compared to adherent ones, and PHQ-9 scores grew consistently with MMAS-4 scores (see Table 1 and Figure 1 ).
Non-adherent respondents were significantly less satisfied with their antidepressant medication (4.9 vs. 5.3, see Table 1 ).
• Respondents recruited from an internet panel using a random stratified sampling framework to ensure the demographic composition (with respect to age and gender) is representative of the adult Brazilian population based on the data from International Data Base of the U.S. Census Bureau and Organization for Economic Cooperation and Development.
Of the 24,000 total NHWS respondents, 22,744 had a complete record of responses (94%).
Of the latter, 2,721 (12%) reported a diagnosis of depression and 1,457 (6%) had a prescription medication for depression (Rx). Those with an Rx constituted our sample.
Data source Sample Measures

Demographics and health characteristics
Depression severity
Medication Adherence
Outcome measures
Age, gender, marital status, education, household income, insurance type.
Body mass index (BMI), smoking status, alcohol use, exercise behavior. The Charlson comorbidity index (CCI) was also examined for general comorbidity burden.
Patient Health Questionnaire-9 (PHQ-9) to assess severity of depression (Minimal, Mild, Moderate, Moderately Severe, Severe) in respondents with a physician diagnosis of depression.
9
Medication Status: respondents were asked if they were currently taking a prescription medication for depression.
Morisky Medication Adherence Scale-4 (MMAS-4)
10 was used to categorize those with low adherence (score ≥ 3) as "non-adherent" and the others (medium/high adherence, score ≤ 2) as "adherent." with Absenteeism: (% time missed from work due to health problems), Presenteeism (% time impaired while working), Overall Work Impairment (% time overall work productivity impaired as a result of absenteeism and presenteeism) and Activity Impairment (% time health problems affected regular activities)
Healthcare resource use: frequency of various forms of healthcare resource use for the past 6 months, visits to Primary care physician (PCP), Specialist (psychiatrist or psychologist) and Emergency room (ER), and Hospitalization Adherent respondents (according to MMAS-4) were compared to the non-adherent on severity (PHQ-9), socio-demographics, health characteristics, health-related quality of life (SF-12 or SF-36), work productivity and activity impairment (WPAI) and healthcare resource use (physician, hospital and emergency visits) using chi-squared tests for categorical variables and t-tests for cardinal variables.
A general linear modeling (GLM) approach was used to test the association of adherence with depression and other outcomes (HRQoL, WPAI, resource use) while controlling for covariates (socio-demographics and health characteristics). Non-adherence showed effects in terms of burden of disease. The Mental Component Summary of the SF-12 or SF-36v2 measuring quality of life was lower for the non-adherent group (MCS: 33 vs. 36) and also had lower Health Utility score (.59 vs. .60, see Figure 2) • No significant difference was detected in healthcare resource utilization after controlling for covariates(see Figure 4 ).
Statistical analyses
•
Figure 1. Depression severity (PHQ-9)
Severity of depression measured by the PHQ-9 (score: 0-27) against adherence to antidepressants measured by MMAS-4 (score: 0-4). Non-adherent in yellow; adherent in red; 3rd-degree polynomial regression line in grey; error bars: standard error of the mean; starred difference: p < 0.01.
